James W. Carroll

Jim Carroll
Jim Carroll
Director of the Office of National Drug Control Policy
	In office; January 3, 2019 – January 20, 2021; Acting: February 9, 2018 – January 3, 2019
President	Donald Trump
Preceded by	Rich Baum (Acting)
Succeeded by	Regina LaBelle (Acting)
White House Principal Deputy Chief of Staff
	In office; December 6, 2017 – February 9, 2018
President	Donald Trump
Preceded by	Kirstjen Nielsen
Succeeded by	Zachary Fuentes
Personal details
Political party	Republican
Education	University of Virginia (BA); George Mason University (JD)

James W. Carroll Jr. is an American attorney and government appointee, who served as director of the Office of National Drug Control Policy in the Trump Administration from February 9, 2018 until January 20, 2021.^[1]^[2]

After being confirmed by the U.S. Senate on January 2, 2019, he was sworn in by Vice President Mike Pence on January 31.^[3] Earlier, Carroll had served as the White House Deputy Chief of Staff.^[4] Prior to that he was General Counsel in the Office of Management and Budget, and an attorney in the Office of the White House Counsel for Presidents Donald Trump and George W. Bush.^[5]

References[]

^ "President Donald J. Trump Announces Appointments for the Executive Office of the President". whitehouse.gov. Retrieved February 9, 2018 – via National Archives.
^ "PN1864 — James W. Carroll Jr. — Executive Office of the President". U.S. Congress. Retrieved April 26, 2018.
^ "APhA Attends Swearing-In Ceremony of National Drug Control Policy Director". American Pharmacists Association. February 4, 2019. Retrieved March 16, 2019.
^ Restuccia, Andrew; Karni, Annie (December 21, 2017). "Trump eyes former aides as West Wing staffers depart". Politico.
^ "President Donald J. Trump Announces Key Additions to the Office of the White House Counsel". whitehouse.gov. Retrieved March 7, 2017 – via National Archives.

External links[]

Media related to James W. Carroll at Wikimedia Commons

Political offices
Preceded by Rich Baum Acting	Director of the Office of National Drug Control Policy 2018–2021 Acting: 2018–2019	Succeeded by Regina LaBelle Acting

[1] "President Donald J. Trump Announces Appointments for the Executive Office of the President". whitehouse.gov. Retrieved February 9, 2018 – via National Archives.

[2] "PN1864 — James W. Carroll Jr. — Executive Office of the President". U.S. Congress. Retrieved April 26, 2018.

[3] "APhA Attends Swearing-In Ceremony of National Drug Control Policy Director". American Pharmacists Association. February 4, 2019. Retrieved March 16, 2019.

[4] Restuccia, Andrew; Karni, Annie (December 21, 2017). "Trump eyes former aides as West Wing staffers depart". Politico.

[5] "President Donald J. Trump Announces Key Additions to the Office of the White House Counsel". whitehouse.gov. Retrieved March 7, 2017 – via National Archives.

[1]

[2]

[3]

[4]

[5]

Jim Carroll


Director of the Office of National Drug Control Policy
In office January 3, 2019 – January 20, 2021 Acting: February 9, 2018 – January 3, 2019
President	Donald Trump
Preceded by	Rich Baum (Acting)
Succeeded by	Regina LaBelle (Acting)
White House Principal Deputy Chief of Staff
In office December 6, 2017 – February 9, 2018
President	Donald Trump
Preceded by	Kirstjen Nielsen
Succeeded by	Zachary Fuentes

Personal details
Political party	Republican
Education	University of Virginia (BA) George Mason University (JD)